EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Identification of a targetable JAK-STAT enriched androgen receptor and androgen receptor splice variant positive triple-negative breast cancer subtype

Sarah Asemota, Wendy Effah, Kirsten L Young, Jeremiah Holt, Linnea Cripe, Suriyan Ponnusamy, Thirumagal Thiyagarajan, Dong-Jin Hwang, Yali He, Keely Mcnamara, Daniel Johnson, Yinan Wang und 15 weitere

Cell Reports · 2023

DOI: 10.1016/j.celrep.2023.113461 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Reports, 2023. Verfasst von Sarah Asemota und 26 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, College of Medicine, University of Tennessee Health Science Center, Memphis, TN 38103, USA. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, National Cancer Institute, US Department of Defense.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Triple-negative breast cancer (TNBC) is an aggressive subtype with no targeted therapeutics. The luminal androgen receptor (LAR) subtype constitutes 15% of TNBC and is enriched for androgen receptor (AR) and AR target genes. Here, we show that a cohort of TNBC not only expresses AR at a much higher rate (∼80%) but also expresses AR splice variants (AR-SVs) (∼20%), further subclassifying LAR-TNBC. Higher AR and AR-SV expression and corresponding aggressive phenotypes are observed predominantly in specimens obtained from African American women. LAR TNBC specimens are enriched for interferon, Janus kinase (JAK)-signal activator and transducer (STAT), and androgen signaling pathways, which are exclusive to AR-expressing epithelial cancer cells. AR- and AR-SV-expressing TNBC cell proliferation and xenograft and patient-tumor explant growth are inhibited by AR N-terminal domain-binding selective AR degrader or by a JAK inhibitor. Biochemical analysis suggests that STAT1 is an AR coactivator. Collectively, our work identifies pharmacologically targetable TNBC subtypes and identifies growth-promoting interaction between AR and JAK-STAT signaling.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Triple Negative Breast NeoplasmsHumansFemaleReceptors, AndrogenSignal TransductionCell ProliferationGene Expression Regulation, Neoplastic

Stichwörter der Autor:innen

ARAR splice variantAR-SVAR-V7CP: CancerJAK STAT pathwayLAR TNBCSARDTNBCandrogen receptorcoactivatorluminal androgen receptor TNBCruxolitinibselective AR degradertriple-negative breast cancer

Substanzen

Receptors, Androgen

Autor:innen und Institutionen

  • Department of Medicine, College of Medicine, University of Tennessee Health Science Center, Memphis, TN 38103, USA.
  • Department of Surgery, College of Medicine, University of Tennessee Health Science Center, Memphis, TN 38103, USA.
  • Department of Pharmaceutical Sciences, College of Pharmacy, University of Tennessee Health Science Center, Memphis, TN 38103, USA.
  • Department of Pathology, Tohoku University Graduate School of Medicine, Sendai, Miyagi 980-8577, Japan.
  • Molecular Bioinformatics Core, University of Tennessee Health Science Center, Memphis, TN 38103, USA.
  • Department of Pathology, College of Medicine, University of Tennessee Health Science Center, Memphis, TN 38103, USA.

Förderung

  • NCI NIH HHS
  • National Cancer Institute
  • US Department of Defense

Zitieren

APA

Asemota, S., Effah, W., Young, K. L., Holt, J., Cripe, L., Ponnusamy, S., Thiyagarajan, T., Hwang, D. J., He, Y., Mcnamara, K., Johnson, D., Wang, Y., Grimes, B., Khosrosereshki, Y., Hollingsworth, T. J., Fleming, M. D., Pritchard, F. E., Hendrix, A., Khan, F., …, & Narayanan, R. (2023). Identification of a targetable JAK-STAT enriched androgen receptor and androgen receptor splice variant positive triple-negative breast cancer subtype. Cell Reports. https://doi.org/10.1016/j.celrep.2023.113461

Vancouver

Asemota S, Effah W, Young KL, Holt J, Cripe L, Ponnusamy S, et al. Identification of a targetable JAK-STAT enriched androgen receptor and androgen receptor splice variant positive triple-negative breast cancer subtype. Cell Reports. 2023. doi:10.1016/j.celrep.2023.113461

BibTeX
@article{Asemota2023,
  author = {Asemota, Sarah and Effah, Wendy and Young, Kirsten L and Holt, Jeremiah and Cripe, Linnea and Ponnusamy, Suriyan and Thiyagarajan, Thirumagal and Hwang, Dong-Jin and He, Yali and Mcnamara, Keely and Johnson, Daniel and Wang, Yinan and Grimes, Brandy and Khosrosereshki, Yekta and Hollingsworth, T J and Fleming, Martin D and Pritchard, Frances E and Hendrix, Ashley and Khan, Farhan and Fan, Meiyun and Makowski, Liza and Yin, Zheng and Sasano, Hironobu and Hayes, D Neil and Pfeffer, Lawrence M and Miller, Duane D and Narayanan, Ramesh},
  title = {Identification of a targetable JAK-STAT enriched androgen receptor and androgen receptor splice variant positive triple-negative breast cancer subtype},
  journal = {Cell Reports},
  year = {2023},
  doi = {10.1016/j.celrep.2023.113461}
}
Kostenlos starten →